Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients

Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review

Contributors

Anne Eugster - , Chair of Preclinical stem cell therapy and diabetes, Center for Regenerative Therapies Dresden (Author)
Denise Müller - , TUD Dresden University of Technology (Author)
Anne Gompf - , Core Facility Flow Cytometry (Author)
Susanne Reinhardt - , DRESDEN-concept Genome Center (CMCB Core Facility), TUD Dresden University of Technology (Author)
Annett Lindner - , TUD Dresden University of Technology (Author)
Michelle Ashton - , TUD Dresden University of Technology (Author)
Nick Zimmermann - , TUD Dresden University of Technology (Author)
Stefan Beissert - , Department of Dermatology (Author)
Ezio Bonifacio - , Chair of Preclinical stem cell therapy and diabetes, Center for Regenerative Therapies Dresden, University Medicine (Faculty of Medicine and University Hospital) (Author)
Claudia Günther - , Department of Dermatology (Author)

[This corrects the article DOI: 10.3389/fimmu.2022.897500.].

No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

PubMed	36518762
unpaywall	10.3389/fimmu.2022.1094578

dendritic Cells (DC), Lamin A/C, LMNA, monogenic familial chilblain lupus, SLE, Trex1, Type I interferons